Drug · DIN 02431300
EZETIMIBE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since October 2, 2026; first marketed October 8, 2014.
- Drug Identification Number (DIN)
- 02431300
- Company (DIN owner)
- Sanis Health Inc.Brampton, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Ezetimibe C10AX09
- Class
- Human
- Record last updated
- October 5, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| EZETIMIBE | 10 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- October 2, 2026: NOC 38398Abbreviated New Drug Submission (ANDS) · Administrative: Licensing Agreement between two manufacturers
- January 13, 2022: NOC 27388Abbreviated New Drug Submission (ANDS) · Administrative: Licensing Agreement Between Two Companies
- January 7, 2015: NOC 16497Abbreviated New Drug Submission (ANDS) · Licensing agreement between two companies
- September 26, 2014: NOC 16136Abbreviated New Drug Submission (ANDS) · Licensing agreement between two companies
Other DINs named EZETIMIBE
- DIN 02422549 · Marketed
- DIN 02478544 · Marketed
- DIN 02429659 · Dormant